Targeted Agents in Chronic Lymphocytic Leukemia (CLL): Advancements in Overall Survival Outcomes?

被引：0
|
作者：
Molica, Stefano [1 ]
Shanafelt, Tait D. [2 ]
Allsup, David [3 ]
Giannarelli, Diana [4 ]
机构：
[1] Hull Univ Teaching Hosp NHS Trust, Dept Hematol, Kingston Upon Hull, N Humberside, England
[2] Stanford Univ, Div Hematol, Dept Med, Stanford, CA USA
[3] Castle Hill Hosp, Cottingham, England
[4] B Fdn Policlin Univ A Gemelli, IRCCS, Biostat Unit, Rome, Italy
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-180699
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Apoptosis and Proliferation Synergistically Determine Overall Survival in Chronic Lymphocytic Leukemia (CLL)
    Del Poeta, Giovanni
    Dal Bo, Michele
    Buccisano, Francesco
    Pozzo, Federico
    Del Principe, Maria Ilaria
    Bulian, Pietro
    Rossi, Davide
    Venditti, Adriano
    de Fabritiis, Paolo
    Gaidano, Gianluca
    Amadori, Sergio
    Gattei, Valter
    BLOOD, 2015, 126 (23)
  • [2] Targeted Therapy in Chronic Lymphocytic Leukemia (CLL)
    Erin M. Pettijohn
    Shuo Ma
    Current Hematologic Malignancy Reports, 2017, 12 : 20 - 28
  • [3] Targeted Therapy in Chronic Lymphocytic Leukemia (CLL)
    Pettijohn, Erin M.
    Ma, Shuo
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2017, 12 (01) : 20 - 28
  • [4] Novel Agents in Chronic Lymphocytic Leukemia (CLL)
    Danilov, Alexey V.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S30 - S31
  • [5] Targeted Agents in Chronic Lymphocytic Leukemia
    O'Brien, Susan M.
    Smith, Ashbel
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2014, 12 (01) : 9 - 11
  • [6] Comparing overall survival (OS) outcomes in patients with newly diagnosed chronic lymphocytic leukemia (CLL) with normal life expectancy.
    Furman, Richard R.
    Allan, John N.
    Howes, Angela J.
    Mahler, Michelle
    Wildgust, Mark A.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (03)
  • [7] Targeted agents in chronic lymphocytic leukemia (CLL): data on outcomes and subsequent therapies of patients observed within the German CLL Study Group (GCLLSG) registry
    Kutsch, Nadine
    Ligtvoet, Rudy
    Robrecht, Sandra
    Linde, Hartmut
    Illmer, Thomas
    Doerfel, Steffen
    Lipke, Jorg
    Aldaout, Ali
    Schlag, Rudolf
    Dengler, Jolanta
    Al-Sawaf, Othman
    Langerbeins, Petra
    Cramer, Paula
    Eichhorst, Barbara
    Hallek, Michael
    Fischer, Kirsten
    Fink, Anna
    LEUKEMIA & LYMPHOMA, 2023, 64 : S125 - S126
  • [8] Chronic lymphocytic leukemia (CLL): New insight on the pathogenesis of CLL cell survival
    Lagneaux, L
    Delforge, A
    Dejeneffe, M
    Massy, M
    Bernier, M
    Bron, D
    7TH ANNUAL MEETING OF THE EUROPEAN HAEMATOLOGY ASSOCIATION, 2002, : 193 - 198
  • [9] Chronic Lymphocytic Leukemia: Exploiting Vulnerabilities with Targeted Agents
    Maly, Joseph
    Blachly, James S.
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2016, 11 (01) : 52 - 60
  • [10] Targeted Agents for the Frontline Management of Chronic Lymphocytic Leukemia
    Burger, Jan A.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2016, 14 (05) : 7 - 12
12345